Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

C Frank Bennett

Evp, Chief Scientific Officer at Ionis Pharmaceuticals Inc (IONS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $16.7M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 9SEC IONSIonis Pharmaceuticals Inc Sell Plan 5,53675,018 held (−7%) $83.58 $463K -45.8%
Jul 9SEC IONSIonis Pharmaceuticals Inc Sell Plan 15,000 $85.46 $1.3M -47.0%
Mar 5SEC IONSIonis Pharmaceuticals Inc Sell Plan 71,60094,043 held (−43%) $79.10 $5.7M -42.8%
Mar 5SEC IONSIonis Pharmaceuticals Inc Sell Plan 12,68781,356 held (−13%) $79.88 $1.0M -43.3%
Mar 5SEC IONSIonis Pharmaceuticals Inc Sell Plan 80280,554 held (−1%) $80.76 $65K -43.9%
Feb 4SEC IONSIonis Pharmaceuticals Inc Sell Plan 20,00080,293 held (−20%) $82.60 $1.7M -45.2%
Feb 4SEC IONSIonis Pharmaceuticals Inc Sell Plan 48,62680,293 held (−38%) $83.03 $4.0M -45.5%
Feb 4SEC IONSIonis Pharmaceuticals Inc Sell Plan 16,46380,293 held (−17%) $83.03 $1.4M -45.5%
Feb 2SEC IONSIonis Pharmaceuticals Inc Sell 5,885100,293 held (−6%) $82.95 $488K -45.4%
Jan 20SEC IONSIonis Pharmaceuticals Inc Sell 8,97794,757 held (−9%) $75.15 $675K -39.7%
  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $463K of IONS at $83.58 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $1.3M of IONS at $85.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $5.7M of IONS at $79.10 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $1.0M of IONS at $79.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $65K of IONS at $80.76 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Chief Scientific Officer C Frank Bennett sold $1.7M of IONS at $82.60 — pre-scheduled 10b5-1 plan sale.